Google Übersetzer
Cyclerion Therapeutics, Inc.
About
3.16USD+0.08 +2.60%
Closed • Updated at 09:43 GMT+00:00Market Cap$13.68M
Volume15.7K
Beta5.26
RSI54.10
Cyclerion Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 1 2026
Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement
Feb 17 2026
Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
Jan 5 2026
Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression
Sep 23 2025
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
Aug 7 2024
Regina Graul, Ph.D., Promoted to Chief Executive Officer
Recent Videos
2025-11-11 04:00:43 CYCU Level 2 and Time & Sales
May 07, 2026
CYCN STOCK : SHARP UPSWING | CYCLERION THERAPEUTICS STOCK
May 03, 2026
Cyclerion Stock Analysis – Massive Merger Behind the Surge
Apr 02, 2026
Why is Cyclerion Therapeutics Inc (CYCN) up +311.6% today?
Apr 02, 2026